IP Verse

Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof

Patent No. EP2905030 (titled "Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses Thereof") was filed by E R Squibb & Sons on Aug 11, 2009. The application was issued on Nov 6, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSAug 5, 2020HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2905030

E R SQUIBB & SONS
Application Number
EP15156647A
Filing Date
Aug 11, 2009
Status
Revoked
Aug 22, 2025
Publication Date
Nov 6, 2019
External Links
Slate, Register , Google Patents